Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Recursion Pharmaceuticals
Biotech
Recursion's new CEO is bringing the AI outfit back to earth
Najat Khan, Ph.D., has a practical mind that belies her ultimate ambition—for Recursion to become a generational platform company.
Darren Incorvaia
May 6, 2026 6:30am
Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders
Mar 27, 2026 11:05am
Recursion refreshes leadership with CEO swap—Chutes & Ladders
Nov 7, 2025 8:30am
BMS removes 2 clinical programs from pipeline
Oct 30, 2025 1:14pm
Rallybio shifts gears, cashing out of Recursion pact
Jul 8, 2025 8:59am
Recursion lays off 20% of staff in wake of pipeline cutbacks
Jun 10, 2025 9:25am
